دMEET “THE FAB FOUR!”

PART OF OUR EVER-INCREASING POPULATION OF YOUNG ADULTS WITH PROGERIA.

Before PRF, the average lifespan for individuals with Progeria was just 13 years. Today, thanks to your support, the development of lonafarnib, and PRF’s ongoing research, more young adults are living with Progeria – growing a remarkable and hopeful population that includes Kaylee (22), Amber (19), Michiel (27), and Merlin (24).

PRF is now advancing SamPro-2, a gene editing therapy that has permanently corrected the exact DNA error that causes Progeria in mouse models, toward human trials.

This is the moment everything changes. And you can be ONE to make the cure POSSIBLE.